Your AI-Trained Oncology Knowledge Connection!

Advancements in the Management of R/R AML: ASH 2024 : Episode 12

Opinion

Video

February 12, 2025

Closing Perspectives on R/R AML Treatment Advances

Author(s):

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO ,James Blachly, MD

Panelists discuss future perspectives on the role of menin inhibitors in the treatment of acute lymphoblastic leukemia (AML), exploring potential advancements and clinical implications.

EP: 1.Treatment Strategies for Relapsed/Refractory AML Patients

EP: 2.Treatment Goals and Unmet Needs in R/R AML

EP: 3.Navigating Challenges in Second- and Third-Line AML Therapy

EP: 4.Revumenib’s FDA Approval and Clinical Implications

EP: 5.Efficacy and Potential of Revumenib in KMT2A-Translocated Leukemia

EP: 6.Adverse Event Management and Patient Safety With Revumenib

EP: 7.MRD Testing and the Role of Revumenib in Treatment Response

EP: 8.Integrating Revumenib Into Current R/R AML Treatment Paradigms

EP: 9.Genetic Testing and Molecular Profiling in AML

EP: 10.Emerging Combination Strategies and Preclinical Findings

EP: 11.Future Perspectives on Menin Inhibitors in Acute Leukemias

Now Viewing

EP: 12.Closing Perspectives on R/R AML Treatment Advances

Video content above is prompted by the following:

Dr. LeBlanc to ask GROUP: Please share future perspectives on the role of menin inhibitors in AML treatment.

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest Conference Coverage

Physical Functioning Measures May Predict Survival Outcomes, ICANS Risk With CAR T-Cell Therapy in NHL

First-Line Atezolizumab Is Suitable in Platinum-Based Chemotherapy Ineligible mUC

Adjuvant CDK4/6 Inhibitors Lay a Solid Treatment Foundation in HR+, HER2– Breast Cancer

Ocular AEs From Mirvetuximab Soravtansine Do Not Impact HRQOL in FRα+ Platinum-Resistant Ovarian Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512